For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

New York Blood Center, Inc.

USPTO Granted Patents = 193

CIPO Patents = 10

EPO Patents = 13

Trademarks = 17

Forward Citations = 3,260

Loading Chart...

Loading Chart...

137 inventors (with patents filed for the assignee):

Bernard Horowitz (26 out of 28 patents)

Shibo Jiang (23 out of 26 patents)

Asim Kumar Debnath (21 out of 21 patents)

4. Alexander Robert Neurath (21 out of 24 patents)

5. Ehud Ben-Hur (18 out of 19 patents)

6. Alfred M Prince (13 out of 16 patents)

7. Francesca Curreli (11 out of 11 patents)

8. Beth H Shaz (9 out of 9 patents)

9. Christopher D Hillyer (9 out of 9 patents)

10. Bohdan J Kudryk (9 out of 9 patents)

11. Lanying Du (8 out of 8 patents)

12. Nathan Strick (8 out of 11 patents)

13. Henrietta Margolis-Nunno (8 out of 8 patents)

14. Bolanle Williams (8 out of 8 patents)

15. A Robert Neurath (8 out of 9 patents)

Core Competencies:

Biomarkers

Immunogenic Compositions

Filarial Parasites

Engineered Red Blood Cells

Zika Virus

Induced Pluripotent Stem Cells

HIV Inhibitors

Influenza Antibodies

Blood Pooling

Antiviral Peptides

Megakaryocyte Production

Universal Detection Systems

193 patents: Sort by Forward Citations

1. 12311016 - Biomarkers and immunogenic compositions for filarial parasites (2025-05-27),

2. 12258582 - Method of blood pooling and storage (2025-03-25),

3. 12251432 - Biomarkers and immunogenic compositions for filarial parasites (2025-03-18),

4. 12156908 - Virus like nanoparticle compositions and methods thereof (2024-12-03),

5. 12123020 - Engineered red blood cells having rare antigen phenotypes (2024-10-22),

6. 12064476 - Zika virus immunogenic compositions (2024-08-20),

7. 11834757 - HLA homozygous induced pluripotent stem cell (iPSC) libraries (2023-12-05),

8. 11831705 - Mobile file transfer methods and apparatus (2023-11-28),

9. 11708559 - Engineered red blood cells having rare antigen phenotypes (2023-07-25),

10. 11571409 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2023-02-07),

11. 11388221 - Mobile file transfer methods and apparatus (2022-07-12),

12. 11103575 - Immunogenic composition for MERS coronavirus infection (2021-08-31),

13. 11059808 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2021-07-13),

14. 10938885 - Mobile file transfer methods and apparatus (2021-03-02),

15. 10869856 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2020-12-22),

The New York Blood Center (NYBC) is a non-profit organization that is one of the largest independent community-based blood centers in the world. Established in 1964, NYBC provides a wide range of blood and transfusion-related products and services. With a mission to save lives and bring hope to patients in need, NYBC collects, processes, and distributes approximately 2,000 units of blood each day to serve the healthcare needs of various communities. Through its extensive network of donor centers, community blood drives, and partnerships with hospitals and healthcare organizations, NYBC plays a critical role in ensuring a safe and sufficient blood supply for transfusion therapy. Visit their website for more information on how to donate, volunteer, or support their life-saving efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

193 Patents

#59 in New York, NY

#125 in New York

#2,059 in US

#4,242 in the World

New York, NY, United States of America

New York Blood Center, Inc.

Forward Citations = 3,260

137 inventors:

Bernard Horowitz (26 out of 28 patents)

Shibo Jiang (23 out of 26 patents)

Asim Kumar Debnath (21 out of 21 patents)

4. Alexander Robert Neurath (21 out of 24 patents)

5. Ehud Ben-Hur (18 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…